Stereotaxis Total Liabilities 2010-2024 | STXS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Stereotaxis total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Stereotaxis total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$211B
Intuitive Surgical (ISRG)	$191.1B
Alcon (ALC)	$45.7B
IQVIA Holdings (IQV)	$39.8B
Edwards Lifesciences (EW)	$39.1B
IDEXX Laboratories (IDXX)	$35.5B
DexCom (DXCM)	$27.3B
Waters (WAT)	$22.8B
SONOVA HOLDING (SONVY)	$22.1B
STERIS (STE)	$21.6B
Hologic (HOLX)	$18.3B
Sysmex ADR (SSMXY)	$12.9B
Fresenius Medical Care AG KGaA (FMS)	$12.5B
Globus Medical (GMED)	$11B
Teleflex (TFX)	$9.1B
Penumbra (PEN)	$9.1B
Masimo (MASI)	$8.7B
Glaukos (GKOS)	$7.8B
PROCEPT BioRobotics (PRCT)	$5.2B
Integer Holdings (ITGR)	$4.6B
Inari Medical (NARI)	$3B
TransMedics (TMDX)	$2.9B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.8B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2B
Integra LifeSciences Holdings (IART)	$1.9B
RxSight (RXST)	$1.8B
Alphatec Holdings (ATEC)	$1.3B